emerging-infectious-diseases

Documents about emerging-infectious-diseases

• Early response model for containing newly emerging infectious diseases#172248bioRxiv / medRxiv
• An Untapped Resource in Addressing Emerging Infectious Diseases: Traditional Healers#493964Digital Repository @ Maurer Law
• EBOla Post-Exposure Prophylaxis#245567ClinicalTrials.gov
• Reducing Antiretroviral Treatments#913695ClinicalTrials.gov
• Lipopeptide Immunisation With GTU-multiHIV Trial#454062ClinicalTrials.gov
• Gut-Associated Lymphocyte Trafficking#994514ClinicalTrials.gov
• Current Topics in Emerging and Reemerging Zoonoses#478354DOAB PROD Instance
• The Globalization of Public Health: Emerging Infectious Diseases and International Relations#493932Digital Repository @ Maurer Law
• Cohorte Nationale VIH-2#861820ClinicalTrials.gov
• Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset#863256ClinicalTrials.gov
• Images of Emerging and Exotic Diseases of Animals#239212Iowa State University Digital Repository
• Post-COVID-19 Condition: Observational Study in Vietnam#812898ClinicalTrials.gov
• Vaccine Responses to SARS-CoV-2 and Other Emerging Infectious Diseases#832389ClinicalTrials.gov
• Characterization and control of emerging viral diseases in Cambodia : insights from bat coronaviruses and chikungunya virus#333872HAL (France)
• Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C#1007872ClinicalTrials.gov
• Probabilistic Invasion Underlies Natural Gut Microbiome Stability#624247eScholarship
• Spatiotemporal Dynamics of Dengue Risk in Bangladesh: A GIS Based Approach#624395eScholarship
• PoC-HCV Genedrive Viral Detection Assay Validation Study#858382ClinicalTrials.gov
• Immunological Consequences of Intestinal Fungal Dysbiosis#612054eScholarship
• Equipment procurement for laboratory of environmental protection sector （Batch No.3） — China Emerging Infectious Diseases Prevention, Preparedness and Response Project (China)#606584World Bank
• Bacterial Vector-Borne Plant Diseases: Unanswered Questions and Future Directions#619953eScholarship
• Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials#127676ClinicalTrials.gov
• Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa#184705ClinicalTrials.gov
• Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults#448315ClinicalTrials.gov
• Interactions between Bacillus anthracis and Plants May Promote Anthrax Transmission#675873eScholarship
• How Re-Infections and Newborns Can Impact Visible and Hidden Epidemic Dynamics?#175862Apollo
• Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection#190637UNSWorks Repository
• Re-emergence of poliomyelitis in the Ukraine, caused by circulating vaccine-derived poliovirus type 2 (cVDPV2)#190651UNSWorks Repository
• Procurement of Negative Pressure Medical Treatment Equipment for Yangpu Port.（1.4.4） — China Emerging Infectious Diseases Prevention, Preparedness and Response Project (China)#783025World Bank
• Structural basis for STAT2 suppression by flavivirus NS5#634732eScholarship
• Interaction of chikungunya virus glycoproteins with macrophage factors controls virion production#642134eScholarship
• Artificial intelligence at the frontlines: Emerging infectious and parasitic diseases in the digital era.#136099PubMed
• Health and economic burdens of emerging infectious diseases in the USA, US territories and globally.#309087NCBI PubMed Central
• Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial#329584ClinicalTrials.gov
• Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea.#415627NCBI PubMed Central
• Epidemiology of Imported Cutaneous Leishmaniasis: A Narrative Review#676115Europe PMC
• Efficacy and Safety of Varenicline Among HIV-infected Patients#857940ClinicalTrials.gov
• Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy.#383469Apollo
• A global metagenomic map of urban microbiomes and antimicrobial resistance#629266eScholarship
• Cytomegalovirus (CMV)-Vectored Vaccines for HIV and Other Pathogens#620067eScholarship
• Impact of heteroresistance on treatment outcomes of people with drug-resistant TB#642084eScholarship
• Evaluation of Third-line cART Regimen in Cambodia (3DICAM)#850261ClinicalTrials.gov
• Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens#491831eScholarship
• The effect of government information release on public protective behaviors during the emerging infectious diseases epidemic in China.#1133NCBI PubMed Central
• An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection#805026ClinicalTrials.gov
• Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients#898679ClinicalTrials.gov
• Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia#1010069ClinicalTrials.gov
• Smartphone barrier: uncovering the digital divide in mHealth prevention among disadvantaged middle-aged and older-aged UK communities#339607Apollo
• Small Molecule Calcium Channel Activator Potentiates Adjuvant Activity#675923eScholarship
• Activation of the Listeria monocytogenes Virulence Program by a Reducing Environment#491807eScholarship